Therapies for acute myeloid leukemia: vosaroxin

Vosaroxin, a quinolone-derivative chemotherapeutic agent, was considered a promising drug for the treatment of acute myeloid leukemia (AML). Early-stage clinical trials with this agent led to a large randomized double-blind placebo-controlled study of vosaroxin in combination with intermediate-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayar, Hamid, Bashardoust, Parvaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558588/
https://www.ncbi.nlm.nih.gov/pubmed/28860803
http://dx.doi.org/10.2147/OTT.S121477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558588/
https://www.ncbi.nlm.nih.gov/pubmed/28860803
http://dx.doi.org/10.2147/OTT.S121477

Ejemplares similares